Found: 15
Select item for more details and to access through your institution.
Scientific Review Committees as part of institutional review of human participant research: Initial implementation at institutions with Clinical and Translational Science Awards.
- Published in:
- Journal of Clinical & Translational Science, 2020, v. 4, n. 2, p. 115, doi. 10.1017/cts.2019.439
- By:
- Publication type:
- Article
A survey of practices for the use of electronic health records to support research recruitment.
- Published in:
- Journal of Clinical & Translational Science, 2017, v. 1, n. 4, p. 246, doi. 10.1017/cts.2017.301
- By:
- Publication type:
- Article
Intradermal carboplatin and ifosfamide extravasation in the mouse.
- Published in:
- 1992
- By:
- Publication type:
- journal article
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 295, doi. 10.1007/s10637-013-9999-7
- By:
- Publication type:
- Article
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 323, doi. 10.1007/s10637-013-0035-8
- By:
- Publication type:
- Article
A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1539, doi. 10.1007/s10637-013-0029-6
- By:
- Publication type:
- Article
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 3, p. 255, doi. 10.1007/s10637-005-3903-z
- By:
- Publication type:
- Article
The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 973, doi. 10.1007/s00280-010-1250-z
- By:
- Publication type:
- Article
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A phase I study of Triapine<sup>®</sup> in combination with doxorubicin in patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- Report
A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 63, n. 1, p. 109, doi. 10.1007/s00280-008-0719-5
- By:
- Publication type:
- Article
A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Phase I trial of perillyl alcohol administered four times daily continuously.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Phase I clinical and pharmacokinetic trial of irofulven.
- Published in:
- 2001
- By:
- Publication type:
- journal article